Effects of Recoverben® on Recovery After Exhaustive Exercise
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of the study is to investigate a pre and post workout supplementation (15 days) with Recoverben® , a Aloysia citriodora extract on recovery after exhaustive exercise. Effects will be investigated with 400mg Recoverben® and compared to placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy-volunteers
Started Oct 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2016
CompletedStudy Start
First participant enrolled
October 1, 2016
CompletedFirst Posted
Study publicly available on registry
October 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2017
CompletedNovember 6, 2017
November 1, 2017
4 months
September 28, 2016
November 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of muscle soreness (VAS) over time
In the current study, pain following eccentric exercise will be assessed by using a 100 mm visual analogue scale after the subjects performing a standardized movement.
Chance over time after 10 days of supplementation (pre stress test and 3h, 24h, 48 h, 96h after stress test)
Secondary Outcomes (7)
Monitoring of related adverse events
During study execution over 15 days
Change of maximal concentric strength/ maximal voluntary contraction (MVC) over time
Chance over time after 10 days of supplementation (pre stress test and 3h, 24h and 48 h after stress test)
Change of pressure pain (Algometry) over time
Chance over time after 10 days of supplementation (pre stress test and 3h, 24h and 48 h after stress test)
Change of retrospective pain (Likert scale) over time
Chance over time after 10 days of supplementation (pre stress test and 24h, 48h, 96h after stress test)
Change of creatine kinase over time
Chance over time after 10 days of supplementation (pre stress test and 3h, 24h and 48 h after stress test)
- +2 more secondary outcomes
Study Arms (2)
Aloysia citriodora extract
ACTIVE COMPARATORDietary Supplement: Aloysia citriodora extract
Placebo Formulation
PLACEBO COMPARATORDietary Supplement: Maltodextrin (no active ingredient)
Interventions
2 capsules with 200mg - daily dosage 400mg
2 capsules with 200mg - daily dosage 400mg
Eligibility Criteria
You may qualify if:
- Subject is able and willing to sign the Informed Consent Form prior to screening evaluations
- Health volunteers: Subject is in good physical and mental health as established by medical his-tory, physical examination, electrocardiogram, vital signs, results of biochemistry and haematology
- Men and women
- Age ≥ 22 and ≤ 50 years
- BMI: 19-30 kg/m2
- Physically active 1-3 times per week
- Nonsmoker
- Able and willing to follow the study protocol procedures
You may not qualify if:
- Relevant history, presence of any medical disorder or chronic intake of medication/dietary supplements (e.g. polyphenols, anti-inflammatory or anti-oxidative drugs or supplements, antihyper-tensive drugs) potentially interfering with this study at screening.
- For this study clinically relevant abnormal laboratory, vital signs or physical findings at screening
- Diabetes or serious cardiovascular diseases
- Change of dietary habits within the 2 weeks prior to screening (for instance start of a diet high in vegetables and fruits (≥ 5 portions per day))
- Diet high in vegetables and fruits ≥ 5 portions per day
- Participants anticipating a change in their lifestyle or physical activity levels during the study.
- Subjects not willing to abstain from intake of analgesic medication (e.g. Aspirin) 24 hours prior to visit 2 until visit 5.
- Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to co-operate during the study.
- Known hypersensitivity to the study preparation or to single ingredients
- Pregnant subject or subject planning to become pregnant during the study; breast-
- Known HIV-infection
- Known acute or chronic hepatitis B and C infection
- Blood donation within 4 weeks prior to visit 1 or during the study.
- Subject involved in any clinical or food study within the preceding month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Biotesys GmbH
Esslingen am Neckar, 73728, Germany
Related Publications (1)
Buchwald-Werner S, Naka I, Wilhelm M, Schutz E, Schoen C, Reule C. Effects of lemon verbena extract (Recoverben(R)) supplementation on muscle strength and recovery after exhaustive exercise: a randomized, placebo-controlled trial. J Int Soc Sports Nutr. 2018 Jan 23;15:5. doi: 10.1186/s12970-018-0208-0. eCollection 2018.
PMID: 29410606DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Claudia Reule, Dr.
BioTeSys GmbH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2016
First Posted
October 4, 2016
Study Start
October 1, 2016
Primary Completion
January 15, 2017
Study Completion
March 15, 2017
Last Updated
November 6, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share